8:08 am Mast Therapeutics Provides Additional Results From Nonclinical Heart Failure Study; Statistically significant and durable reductions in troponin and NT-proBNP
View todays social media effects on MSTX
View the latest stocks trending across Twitter. Click to view dashboard
See who Mast is hiring next, click here to view
